Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pamlico Capital is a middle-market private equity firm based in Charlotte, North Carolina, with a dedicated focus on the healthcare and life sciences services sectors. Established in 1988, the firm specializes in growth equity investments and leveraged buyouts of companies with enterprise values ranging from $50 million to $350 million. Within healthcare, Pamlico targets subsectors such as healthcare IT, pharma services, and specialized clinical providers. The firm actively partners with management teams to scale operations through both organic growth initiatives and strategic acquisitions. Their portfolio has historically included significant players in the life sciences consulting and regulatory compliance space, such as ProPharma Group and Helio Health Group. Since its inception, Pamlico has managed over $4 billion in committed capital across multiple funds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pamlico Capital.